These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 96195)

  • 1. Serum desialylated glycoproteins in patients with hepatobiliary dysfunction.
    Marshall JS; Williams S; Jones P; Hepner GW
    J Lab Clin Med; 1978 Jul; 92(1):30-7. PubMed ID: 96195
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.
    Marshall JS; Green AM; Pensky J; Williams S; Zinn A; Carlson DM
    J Clin Invest; 1974 Sep; 54(3):555-62. PubMed ID: 4137057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acid contents of glycoprotein and seromucoid in liver diseases.
    Kaniak J; Mejbaum-Katzenelenbogen W; Jelewska-Kaniakowa Z; Kudrewicz-Hubicka Z; Kowal-Gierczak B
    Pol Med J; 1970; 9(5):1076-81. PubMed ID: 5510277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Haptoglobin and ceruloplasmin in liver and biliary tract diseases].
    Prellwitz W; Hammar CH; Dudeck J
    Dtsch Med Wochenschr; 1968 Jun; 93(26):1277-81. PubMed ID: 5653473
    [No Abstract]   [Full Text] [Related]  

  • 5. [An evaluation of the determination of serum conjugated cholic acid in patients with hepatobiliary diseases].
    Fan SL; Li ZJ; Chen WY
    Zhonghua Nei Ke Za Zhi; 1982 Jul; 21(7):386-9. PubMed ID: 7172873
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sialic acid of glycoproteins and seromucoid in liver diseases].
    Kaniak J; Mejbaum-Katzenellenbogen ; Jelewska-Kaniakowa Z; Kudrewicz-Hubicka Z; Kowal-Gierczak B
    Pol Tyg Lek; 1969 Dec; 24(51):1953-5. PubMed ID: 5365679
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease.
    Costante G; Sand G; Reding P; Glinoer D
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):392-400. PubMed ID: 3920855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of blood serum lactate dehydrogenase and its isoenzymes in liver and biliary tract diseases].
    Podil'chak EM
    Ter Arkh; 1972 Jul; 44(7):46-8. PubMed ID: 5069977
    [No Abstract]   [Full Text] [Related]  

  • 9. [The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
    Kaulhausen H; Pfeiffer P; Breuer H
    Z Klin Chem Klin Biochem; 1972 Feb; 10(2):51-5. PubMed ID: 4347073
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of blood ammonia level in liver diseases].
    Engelmann L
    Z Gesamte Inn Med; 1970 Dec; 25(23):1049-55. PubMed ID: 4104436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum bile acids in hepatobiliary disease].
    Esquivel López A; González Espinola G; Gutiérrez Nava R; García Arreola RM
    Rev Gastroenterol Mex; 1982; 47(1):9-12. PubMed ID: 7100761
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum squalene levels in hepatobiliary diseases.
    Yamanishi Y; Ikawa S; Hirayama C
    Clin Chim Acta; 1978 Aug; 88(1):105-10. PubMed ID: 679482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discriminatory function of serum proteins in liver and biliary tract diseases].
    Nilius R; Zipprich B; Otto L; Busse HJ
    Z Gesamte Inn Med; 1977 Jun; 32(12):265-70. PubMed ID: 910527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.
    Takikawa H; Beppu T; Seyama Y; Wada T
    Gastroenterol Jpn; 1983 Jun; 18(3):246-51. PubMed ID: 6307803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the action of C-reactive proteins in relation to current liver tests].
    Renger F; Kanehl R; Kanehl E
    Acta Hepatosplenol; 1965; 12(6):337-51. PubMed ID: 5868476
    [No Abstract]   [Full Text] [Related]  

  • 16. [Content of glycoproteids in the blood serum of the patients with chronic inflammatory diseases of the biliary tract and liver].
    Borevskaia BD; Gubergrits EA
    Vrach Delo; 1967 Feb; 2():14-6. PubMed ID: 5617012
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of serum levels of tryptophan in hepatobiliary disease.
    Yoshida K; Hirayama C
    Clin Chim Acta; 1980 Feb; 101(2-3):235-40. PubMed ID: 6244122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of human serum alkaline phosphatase, as investigated by molecular filtration through Sephadex G-200.
    Gabryś K
    Pol Med J; 1971; 10(5):1112-8. PubMed ID: 5133660
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes of plasma fibrinolytic activity in chronic disorders of the liver and biliary tract].
    Pstruzinová H; Jablonská M; Richter V; Pstruzina J
    Sb Lek; 1971 Apr; 73(4):89-98. PubMed ID: 5552779
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated serum levels of a biliary glycoprotein (BGP I) in patients with liver or biliary tract disease.
    Svenberg T; Wahren B; Hammarström S
    Clin Exp Immunol; 1979 May; 36(2):317-25. PubMed ID: 477033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.